<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>358</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>9770525</PubmedId>
            <Abstract>We report the crystal structure of Thermus aquaticus DNA polymerase I in complex with an inhibitory Fab, TP7, directed against the native enzyme. Some of the residues present in a helical conformation in the native enzyme have adopted a gamma turn conformation in the complex. Taken together, structural information that describes alteration of helical structure and solution studies that demonstrate the ability of TP7 to inhibit 100% of the polymerase activity of the enzyme suggest that the change in conformation is probably caused by trapping of an intermediate in the helix-coil dynamics of this helix by the Fab. Antibodies directed against modified helices in proteins have long been anticipated. The present structure provides direct crystallographic evidence. The Fab binds within the DNA binding cleft of the polymerase domain, interacting with several residues that are used by the enzyme in binding the primer:template complex. This result unequivocally corroborates inferences drawn from binding experiments and modeling calculations that the inhibitory activity of this Fab is directly attributable to its interference with DNA binding by the polymerase domain of the enzyme. The combination of interactions made by the Fab residues in both the polymerase and the vestigial editing nuclease domain of the enzyme reveal the structural basis of its preference for binding to DNA polymerases of the Thermus species. The orientation of the structure-specific nuclease domain with respect to the polymerase domain is significantly different from that seen in other structures of this polymerase. This reorientation does not appear to be antibody-induced and implies remarkably high relative mobility between these two domains.</Abstract>
            <ArticleYear>1998</ArticleYear>
            <ArticlePages>12562-7</ArticlePages>
            <ArticleTitle>Crystal structure of Taq DNA polymerase in complex with an inhibitory Fab: the Fab is directed against an intermediate in the helix-coil dynamics of the enzyme.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Murali</LastName>
                    <ForeName>R</ForeName>
                </Author>
                <Author>
                    <LastName>Sharkey</LastName>
                    <ForeName>D J</ForeName>
                </Author>
                <Author>
                    <LastName>Daiss</LastName>
                    <ForeName>J L</ForeName>
                </Author>
                <Author>
                    <LastName>Murthy</LastName>
                    <ForeName>H M</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Pathology, University of Pennsylvania, Philadelphia, PA, 19104, USA.</Affiliations>
            <ArticleChemicalList>Immunoglobulin Fab Fragments;Taq Polymerase</ArticleChemicalList>
            <ArticleMeshHeadingsList>Crystallography, X-Ray; Immunoglobulin Fab Fragments(chemistry); Molecular Sequence Data; Protein Conformation; Taq Polymerase(chemistry; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>95</Volume>
                <Issue>21</Issue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <Issn>0027-8424</Issn>
                <MedlineTa>Proc Natl Acad Sci U S A</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>TP7 Fab epitope of Taq DNA polymerase I</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>R313, K314, S383, T385, T386, E388, E397, W398, E471, P481, L484, N485, K511, R512, S515, R536, K542, S543, T544, Y545, I546, D547, P548, A568, A570, N580, R728</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>P19821.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>271</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2 and PDB 1BGX</LocationOfData>
                <EpitopeId>77382</EpitopeId>
                <ReferenceRegion>R313, K314, S383, T385, T386, E388, E397, W398, E471, P481, L484, N485, K511, R512, S515, R536, K542, S543, T544, Y545, I546, D547, P548, A568, A570, N580, R728</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 1, 2, 3, 4, Table 2 and PDB 1BGX</LocationOfData>
                        <BCellId>462</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000253</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KTLEEGRRRGYVETLFGR</LinearSequence>
                                            <StartingPosition>709</StartingPosition>
                                            <EndingPosition>726</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P19821.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>271</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Ribi</Adjuvant>
                                <DoseSchedule>3 doses over 4 months</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the reference: Scalice et al. (1994) J Immunol Methods 172: 147 [PMID: 7518481]. Mice were immunized three times over 4 months with TaqP peptide 709-726 conjugated to a carrier protein.  The mice were then re-immunized five times i.p. with 60 Âµg Taq Polymerase at &gt; 3-week intervals over nine months.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.3</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of Fab TP7 on TaqP was determined from the crystal structure of the complex, determined by molecular replacement. The inhibitory activity of TP7 Fab is directly attributable to its interference with DNA binding by the polymerase domain of the enzyme. Fab binds the region of TaqP involved in DNA binding.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>TP7</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>TP7</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1BGX_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1BGX_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Taq DNA polymerase I</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P19821.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>271</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1BGX</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>T</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>There are conformational changes in bound antibody comparing with the free antibody [PDB: 1AY1]: there is a large movement of the framework residue of the heavy chain Thr87. Much larger changes are seen in regions of TaqP contacted the TP7 antibody in comparison with the free TaqP [PDB: 1TAQ].</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>T: R313, K314, S383, T385, T386, E388, E397, W398, E471, P481, L484, N485, K511, R512, S515, R536, K542, S543, T544, Y545, I546, D547, P548, A568, A570, N580, R728</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: S53:H2, T55:H2, T56:H2, D57:H2, K63:H2, S64:H2, G98:H3, Y99:H3, W100:H3, Y101:H3, W105:FR; L: Y32:L1, Y34:L1, D50:L2, L54:L2, G57:L2, S121:L3, S122:L3, L46:FR, Y49:FR, V58:FR;</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>814.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>891.0</ContactAreaForAntibody>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>T: R313, K314, E315, L352, P382, S383, T385, T386, E388, R392, E397, W398, T399, E400, S460, A464, I467, E471, F475, P481, F482, N483, L484, N485, S486, T506, E507, K511, R512, S515, A516, I532, Y535, R536, T539, L541, K542, S543, T544, Y545, I546, D547, P548, N565, A568, T569, A570, D578, N580, N583, R728, D732</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: T25, G26, W47, S53, G54, T55, T56, D57, Y58, S61, K63, S64, S67, S73, Y97, G98, Y99, W100, Y101, D103, V104, W105; L: Y32, M33, Y34, W35, Y36, Q37, G41, S43, R45, L46, Y49, D50, N53, L54, A55, S56, G57, V58, P59, V60, R61, E79, E81, D82, W91, S92, T93</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>2952.1</ContactAreaForAntigen>
                                <ContactAreaForAntibody>2861.6</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

